TORONTO, ON--(Marketwired - April 10, 2014) - Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce its wholly-owned subsidiary, All Star Health Brands, Inc., owner of the revolutionary TapouT Muscle Recovery product line, will be attending the upcoming ECRM (Efficient Collaborative Retail Marketing) EPPS (Efficient Program Planning Sessions) event.
Throughout the event, representatives from All Star Health Brands will hold more than 80 meetings with some of the largest retailers and distributors in the country. Each meeting will be 20 minutes in length, and will allow representatives from the company to present information on their leading product line, TapouT Muscle Recovery, to buyers from major companies like Walmart, CVS and Walgreens, among many others.
"We are thrilled about the opportunity to present our product line to such an esteemed audience," said Dr. Daniel Bagi, President of All Star Health Brands. "TapouT Muscle Recovery is a truly extraordinary product line that is certain to be well received at this event. TapouT athletes and active individuals can quickly rebound from fatigue and soreness following an intense workout. Its unique formula also helps build muscle faster and burn fat more quickly, making it ideal for people who want to boost their athletic performance and get in shape as quickly as possible."
TapouT contains a unique mixture of seven different essential oils, which together help reduce pain and muscle fatigue while facilitating the growth of new muscle tissue. It increases blood flow to the muscles without thinning the blood, making it the ideal exercise supplement for individuals suffering from any number of health conditions.
All Star Brands offers a variety of TapouT formulas, including a morning supplement that provides a sustained energy boost, along with TapouT's patented muscle-building formula, as well as an evening supplement, which offers long-lasting pain relief while rebuilding damaged muscle tissue. TapouT also makes a line of topical sprays that may be applied directly to sore muscles for fast relief.
"TapouT is certain to be a hit at the upcoming ECRM EPPS event," said Mitch Gould, CEO of Nutritional Products International (NPI), a brand management firm that provides marketing and sales services for TapouT. "This product is unlike anything else on the market, and it allows athletes to take their training to new heights. We expect TapouT to generate a great deal of interest among the leading retail and distribution companies present at this event."
To learn more about the TapouT line, go to http://www.tapoutmusclerecovery.com.
About Axxess Pharma Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain, - to optimal health management through improved nutritional supplements.
For more information, please visit www.axxesspharmainc.com, or contact Investor Relations at (973) 351-3868.
TapouT is a lifestyle brand that has been at the forefront of Mixed Martial Arts since its inception in 1997. The label is rapidly growing into other sports and categories, offering merchandise for men, women and kids. TapouT has endorsed high-profile professional athletes who compete in sports such as basketball, football, baseball, stock car racing, and most famously, MMA. TapouT is sold in sporting goods stores, specialty retailers and online. For updates and more information, please visit TapouT.com.
Safe Harbor Statement
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.
The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.